Division of Infectious Diseases, Duke University, Durham, North Carolina.
Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
JAMA Netw Open. 2024 Feb 5;7(2):e240473. doi: 10.1001/jamanetworkopen.2024.0473.
Staphylococcus aureus is the leading cause of death due to bacterial bloodstream infection. Female sex has been identified as a risk factor for mortality in S aureus bacteremia (SAB) in some studies, but not in others.
To determine whether female sex is associated with increased mortality risk in SAB.
MEDLINE, Embase, and Web of Science were searched from inception to April 26, 2023.
Included studies met the following criteria: (1) randomized or observational studies evaluating adults with SAB, (2) included 200 or more patients, (3) reported mortality at or before 90 days following SAB, and (4) reported mortality stratified by sex. Studies on specific subpopulations (eg, dialysis, intensive care units, cancer patients) and studies that included patients with bacteremia by various microorganisms that did not report SAB-specific data were excluded.
Data extraction and quality assessment were performed by 1 reviewer and verified by a second reviewer. Risk of bias and quality were assessed with the Newcastle-Ottawa Quality Assessment Scale. Mortality data were combined as odds ratios (ORs).
Mortality at or before 90-day following SAB, stratified by sex.
From 5339 studies retrieved, 89 were included (132 582 patients; 50 258 female [37.9%], 82 324 male [62.1%]). Unadjusted mortality data were available from 81 studies (109 828 patients) and showed increased mortality in female patients compared with male patients (pooled OR, 1.12; 95% CI, 1.06-1.18). Adjusted mortality data accounting for additional patient characteristics and treatment variables were available from 32 studies (95 469 patients) and revealed a similarly increased mortality risk in female relative to male patients (pooled adjusted OR, 1.18; 95% CI, 1.11-1.27). No evidence of publication bias was encountered.
In this systematic review and meta-analysis, female patients with SAB had higher mortality risk than males in both unadjusted and adjusted analyses. Further research is needed to study the potential underlying mechanisms.
金黄色葡萄球菌是细菌性血流感染导致死亡的主要原因。一些研究表明,女性是金黄色葡萄球菌菌血症(SAB)死亡的危险因素,但其他研究并未得出这一结论。
确定女性是否与 SAB 死亡率增加相关。
从建库到 2023 年 4 月 26 日,对 MEDLINE、Embase 和 Web of Science 进行了检索。
纳入的研究符合以下标准:(1)评估成人 SAB 的随机或观察性研究,(2)纳入 200 例或以上患者,(3)报告 SAB 后 90 天内或之前的死亡率,(4)报告按性别分层的死亡率。排除了特定亚人群(如透析、重症监护病房、癌症患者)的研究和纳入多种微生物引起菌血症但未报告 SAB 特定数据的研究。
由 1 名审查员进行数据提取和质量评估,由另 1 名审查员进行验证。使用纽卡斯尔-渥太华质量评估量表评估风险偏倚和质量。将死亡率数据合并为比值比(ORs)。
SAB 后 90 天内或之前的死亡率,按性别分层。
从 5339 项研究中检索到 89 项研究(132582 例患者;50258 例女性[37.9%],82324 例男性[62.1%])。81 项研究(109828 例患者)提供了未调整的死亡率数据,结果显示女性患者的死亡率高于男性患者(合并 OR,1.12;95%CI,1.06-1.18)。32 项研究(95469 例患者)提供了考虑到其他患者特征和治疗变量的调整后死亡率数据,结果显示女性患者的死亡风险相对男性患者仍有显著增加(合并调整后的 OR,1.18;95%CI,1.11-1.27)。未发现发表偏倚的证据。
在这项系统评价和荟萃分析中,未校正和校正分析中,SAB 女性患者的死亡率风险均高于男性患者。需要进一步研究以探讨潜在的潜在机制。